Mutagenesis by asbestos in the lung of λ-lacI transgenic rats

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 553, Issue 1-2, 2004, Pages 67-78

  Topinka, J ^a,b   Loli, P ^c   Georgiadis, P ^c   Dusinska M ^d   Hurbankova M ^d   Kovacikova Z ^d   Volkovova K ^d   Kazimirova A ^d   Barancokova M ^d   Tatrai, E ^e   Oesterle, D ^a   Wolff, T ^a   Kyrtopoulos, S A ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^c INSTITUTE OF BIOLOGY   (Greece)

^d INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^e Jozsef Fodor National Center for Public Health   (Hungary)

Author keywords

alveolar macrophages; AM; BAL; BALF; bronchoalveolar lavage; bronchoalveolar lavage fluid; CM; control mutants; dimethylsulphoxide; DMSO; E; eosine; H; haematoxyline; IL 1 ; interleukin 1 ; malondialdehyde; MDA; MF; mutation frequency; PFU

Indexed keywords

AMOSITE; ASBESTOS; BIOCHEMICAL MARKER; DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASBESTOSIS; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CHEMICAL MUTAGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; EXPOSURE; GENOTOXICITY; LUNG CANCER; LUNG CARCINOGENESIS; LUNG INJURY; MALE; MUTAGENIC ACTIVITY; MUTATION RATE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT; WILD TYPE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ASBESTOS; INFLAMMATION; LUNG; MALONDIALDEHYDE; MUTAGENS; OXIDATIVE STRESS; RATS; REPRESSOR PROTEINS;

ANIMALIA;

EID: 3242880017     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2004.06.023     Document Type: Conference Paper

References (39)

1. Peto J., Hodgson J.T., Matthews F.E., Jones J.R. Continuing increase in mesothelioma mortality in Britain. Lancet. 345:1995;535-539
2. Peto J., Decarli A., La Veccia C., Levis F., Negri E. The European mesothelioma epidemic. Brit. J. Cancer. 79:1999;666-672
3. H. Greim, P. Borm, R. Schins, K. Donaldson, K. Driscoll, A. Hartwig, E. Kuempel, G. Oberdörster, G. Speit, Toxicity of fibers and particles, in: report of the workshop held in Munich, Germany, 26-27 October 2000, Inhalation Toxicol. 13 (2000) 737-754.
4. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, vol. 14, Asbestos, Lyon, 1977, pp. 11-106.
5. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs, vol. 1-42, Lyon, 1987, pp. 106-117, 203.
6. M.C. Jaurand, Use of in-vitro genotoxicity and cell transformation assays to evaluate the potential carcinogenicity of fibres, in: A.B. Kane, P. Boffetta, R. Saracci, J.D. Wilbourn (Eds.), Mechanisms of Fibre Carcinogenesis, IARC Scientific Publications No. 140, IARC, Lyon, 1996, pp. 55-72.
7. A.B. Kane, Mechanisms of mineral fibre carcinogenesis, in: A.B. Kane, P. Boffetta, R. Saracci, J.D. Wilbourn (Eds.), Mechanisms of Fibre Carcinogenesis, IARC Scientific Publications No. 140, IARC, Lyon, 1996, pp. 11-34.
8. Unfried K., Schürkes C., Abel J. Distinct spectrum of mutations induced by crocidolite asbestos: clue for 8-hydroxydeoxyguanosine-dependent mutagenesis in vivo. Cancer Res. 62(1):2002;99-104
9. Kamp W.E., Weitzman S.A. The molecular basis of asbestos induced lung injury. Thorax. 54:1999;638-652
10. Davis J.M.G., Addison J., Bolton R.E. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and by peritoneal injection. J. Exp. Pathol. 67:1986;415-430
11. Hart G.A., Kathman L.M., Hesterberg T.W. In vitro cytotoxicity of asbestos and man-made vitreous fibres: role of fibre length, diameter, and composition. Carcinogenesis. 15:1994;971-977
12. Huang S.L. Amosite, chrysotile and crocidolite asbestos are mutagenic in Chinese hamster lung cells. Mutat. Res. 68:1979;265-274
13. Both K., Henderson D.W., Turner D.R. Asbestos and erionite fibres can induce mutations in human lymphocytes that results in loss of heterozygosity. Int. J. Cancer. 59:1994;538-542
14. Takeuchi T., Morimoto K. Crocidolite asbestos increased 8-hydroxydeoxyguanosine levels in cellular DNA of a human promyelocytic leukemia cell line, HL60. Carcinogenesis. 15:1994;635-639
15. Rihn B., Coulais C., Kauffer E., Bottin M., Martin P., Yvon F., Vigneron J.C., Binet S., Monhoven N., Steiblen G., Keith G. Inhaled crocidolite mutagenicity in lung DNA. Environ. Health Perspect. 108:2000;341-346
16. Hesterberg T.W., Chase G., Axten C.J., Miller W.C., Musselman R.P., Kamstrup O., Hadley J., Morscheidt C., Bernstein D.M., Thevenaz P. Biopersistence of synthetic vitreous fibres and amosite asbestos in the rat lung following inhalation. Toxicol. Appl. Pharmacol. 151:1998;262-275
17. Dycaico J.M., Provost G.S., Kretz P.L., Ranson S.L., Moores J.C., Short J.M. The use of shuttle vectors for mutation analysis in transgenic mice and rats. Mutat. Res. 307:1994;461-478
18. Richard M.J., Giraud P., Meo J., Favier A. High performance liquid chromatographic separation of malondialdehyde-thiobarbituric acid adduct in biological materials (plasma and human cells) using commercially available reagent. J. Chromatogr. 577:1992;9-12
19. Myrvik Q.N., Leake E.S., Farris B. Studies on pulmonary alveolar macrophages from the normal rabbit: a technique to procure them in a high state of purity. J. Immunol. 86:1961;128-132
20. Richards R.J., Davies N., Atkins J., Oreffo V.I.C. Isolation, biochemical characterization and culture of lung type II cells of the rat. Lung. 165:1987;143-158
21. Collins A.R., Dušinská M., Gedik C.M., Stetina R. Oxidative damage to DNA: do we have a reliable biomarker? Environ. Health Perspect. 104:1996;465-469
22. Collins A.R., Dušinská M., Franklin M., Somorovská M., Petrovská H., Duthie S., Fillion L., Panayiotidis M., Rašlová K., Vaughan N. Comet assay in human biomonitoring studies: reliability, validation, and applications. Environ. Mol. Mutagen. 30:1997;139-146
23. Fenech M., Holland N., Chang W.P., Zeiger E., Bonassi S. The human micronucleus project - an international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat. Res. 428:1999;271-283
24. Dörger M., Allmeling A., Kiefmann R., Münzig S., Messmer K., Krombach F. Early inflammatory response to asbestos exposure in rat and hamster lungs: role of inducible nitric oxide synthase. Toxicol. Appl. Pharmacol. 181:2002;93-105
25. Tsuda T., Morimoto Y., Yamato H., Nakamura H., Hori H., Nagata N., Kido M., Higashi T., Tanaka I. Effects of mineral fibers on the expression of genes whose product may play a role in fiber pathogenesis. Environ. Health Perspect. 105(Suppl. 5):1997;1173-1178
26. Harrison P.T.C., Heath J.C. Apparent synergy between chrysotile asbestos and N-nitrosoheptamethylenimine in the induction of pulmonary tumours in rats. Carcinogenesis. 9:1988;2165-2171
27. Harrison P.T.C., Heath J.C. Apparent synergy in lung carcinogenesis: interactions between N-nitrosoheptamethylenimine, particulate cadmium and crocidolite asbestos fibres in rats. Carcinogenesis. 7:1986;1903-1908
28. Both K., Henderson D.W., Turner D.R. Asbestos and erionite fibers can induce mutations in human lymphocytes that resulted in loss of heterozygosity. Int. J. Cancer. 59:1994;538-542
29. Lezon-Geyda K., Jaime C.M., Godbold J.H., Savransky E.F., Hope A., Kheiri S.A., Dzmura Z.M., Uehara H., Johnson E.M., Fasy T.M. Chrysotile asbestos fibers mediate homologous recombination in Rat2λ fibroblasts: Implications for carcinogenesis. Mutat. Res. 361:1996;113-120
30. Boerrigter M.E.T.I. Treatment of lacZ plasmid-based transgenic mice with benzo[a]pyrene: measurement of DNA adduct levels, mutant frequencies and mutant spectra. Environ. Mol. Mutagen. 32:1999;140-147
31. Cheng L., Sonntag D.M., de Boer J.G., Dixon K. Chromium(VI)-induced mutagenesis in the lungs of big blue transgenic mice. J. Environ. Pathol. Toxicol. Oncol. 19(3):2000;239-249
32. Suzuki T., Hayashi M., Ochiai M., Wakabayashi K., Ushijima T., Sugimura T., Nagao M., Sofuni T. Organ variation in the mutagenicity of MeIQ in Big Blue lacI transgenic mice. Mutat. Res. 369:1996;45-49
33. A.R. Brody, P.G. Coin, V.L. Roggli, Persistence of long thin chrysotile asbestos fibers in the peripheral lung tissue of rats, in: Biopersistence of Respirable Synthetic Fibers and Minerals, IARC, Lyon, 1992.
34. Searl A., Buchanan D., Cullen R.T., Jones A.D., Miller B.G., Soutar C.A. Biopersistence and durability of nine mineral fibre types in rat lungs over 12 months. Ann. Occup. Hyg. 43:1999;143-153
35. Mossman B.T., Marsh J.P. Evidence supporting a role for active oxygen species in asbestos-induced toxicity and lung disease. Environ. Health Perspect. 81:1989;91-94
36. McGavran P.D., Brody A.R. Chrysotile inhalation induces tritiated thymidine incorporation by epithelial cells of distal bronchioles. Am. J. Respir. Cell Mol. Biol. 1:1989;231-235
37. Warheit D.B., Snajdr S.I., Hartsky M.A., Frame S.R. Lung proliferative and clearance responses to inhaled para-aramid RFP in exposed hamsters and rats: comparison with chrysotile asbestos fibers. Environ. Health Perspect. 105(Suppl. 5):1997;1219-1222
38. Brody A.R., Overby L.H. Incorporation of tritiated thymidine by epithelial and interstitial cells in bronchiolar-alveolar regions of asbestos exposed rats. Am. J. Pathol. 134:1989;133-140
39. Heddle J.A., Swinger R.R. Risk estimation from somatic mutation assays. Mutat. Res. 365:1996;107-117